<?xml version="1.0" encoding="UTF-8"?>
<ref id="B315-vaccines-08-00036">
 <label>315.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wunderlich</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Brooks</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Panchal</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Rhyasen</surname>
    <given-names>G.W.</given-names>
   </name>
   <name>
    <surname>Danet-Desnoyers</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Mulloy</surname>
    <given-names>J.C.</given-names>
   </name>
  </person-group>
  <article-title>OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues</article-title>
  <source>Blood</source>
  <year>2014</year>
  <volume>123</volume>
  <fpage>e134</fpage>
  <lpage>e144</lpage>
  <pub-id pub-id-type="doi">10.1182/blood-2014-02-556340</pub-id>
  <pub-id pub-id-type="pmid">24778156</pub-id>
 </element-citation>
</ref>
